Copyright Reports & Markets. All rights reserved.

Global Antidepressants Drugs Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Antidepressants Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Tricyclic Antidepressants
      • 1.4.3 Serotonin-norepinephrine Inhibitors
      • 1.4.4 Atypical Antipsychotics
      • 1.4.5 Selective Serotonin Reuptake Inhibitors
      • 1.4.6 Benzodiazepines
      • 1.4.7 Tetracyclic Antidepressants
      • 1.4.8 Monoamine Oxidase Inhibitors
      • 1.4.9 Others
    • 1.5 Market by Application
      • 1.5.1 Global Antidepressants Drugs Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Antidepressants Drugs Market Size
    • 2.2 Antidepressants Drugs Growth Trends by Regions
      • 2.2.1 Antidepressants Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Antidepressants Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Antidepressants Drugs Market Size by by Players
      • 3.1.1 Global Antidepressants Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Antidepressants Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Antidepressants Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antidepressants Drugs Key Players Head office and Area Served
    • 3.3 Key Players Antidepressants Drugs Product/Solution/Service
    • 3.4 Date of Enter into Antidepressants Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Antidepressants Drugs Market Size by Type (2014-2019)
    • 4.2 Global Antidepressants Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Antidepressants Drugs Market Size (2014-2019)
    • 5.2 Antidepressants Drugs Key Players in North America
    • 5.3 North America Antidepressants Drugs Market Size by Type
    • 5.4 North America Antidepressants Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Antidepressants Drugs Market Size (2014-2019)
    • 6.2 Antidepressants Drugs Key Players in Europe
    • 6.3 Europe Antidepressants Drugs Market Size by Type
    • 6.4 Europe Antidepressants Drugs Market Size by Application

    7 China

    • 7.1 China Antidepressants Drugs Market Size (2014-2019)
    • 7.2 Antidepressants Drugs Key Players in China
    • 7.3 China Antidepressants Drugs Market Size by Type
    • 7.4 China Antidepressants Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Antidepressants Drugs Market Size (2014-2019)
    • 8.2 Antidepressants Drugs Key Players in Japan
    • 8.3 Japan Antidepressants Drugs Market Size by Type
    • 8.4 Japan Antidepressants Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Antidepressants Drugs Market Size (2014-2019)
    • 9.2 Antidepressants Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Antidepressants Drugs Market Size by Type
    • 9.4 Southeast Asia Antidepressants Drugs Market Size by Application

    10 India

    • 10.1 India Antidepressants Drugs Market Size (2014-2019)
    • 10.2 Antidepressants Drugs Key Players in India
    • 10.3 India Antidepressants Drugs Market Size by Type
    • 10.4 India Antidepressants Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Antidepressants Drugs Market Size (2014-2019)
    • 11.2 Antidepressants Drugs Key Players in Central & South America
    • 11.3 Central & South America Antidepressants Drugs Market Size by Type
    • 11.4 Central & South America Antidepressants Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Antidepressants Drugs Introduction
      • 12.1.4 Pfizer Revenue in Antidepressants Drugs Business (2014-2019))
      • 12.1.5 Pfizer Recent Development
    • 12.2 AstraZeneca
      • 12.2.1 AstraZeneca Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Antidepressants Drugs Introduction
      • 12.2.4 AstraZeneca Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.2.5 AstraZeneca Recent Development
    • 12.3 Eli Lilly and Company
      • 12.3.1 Eli Lilly and Company Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Antidepressants Drugs Introduction
      • 12.3.4 Eli Lilly and Company Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.3.5 Eli Lilly and Company Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Antidepressants Drugs Introduction
      • 12.4.4 Novartis Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 GlaxoSmithKline
      • 12.5.1 GlaxoSmithKline Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Antidepressants Drugs Introduction
      • 12.5.4 GlaxoSmithKline Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.5.5 GlaxoSmithKline Recent Development
    • 12.6 Otsuka Pharmaceutical
      • 12.6.1 Otsuka Pharmaceutical Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Antidepressants Drugs Introduction
      • 12.6.4 Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.6.5 Otsuka Pharmaceutical Recent Development
    • 12.7 Abbott Laboratories
      • 12.7.1 Abbott Laboratories Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Antidepressants Drugs Introduction
      • 12.7.4 Abbott Laboratories Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.7.5 Abbott Laboratories Recent Development
    • 12.8 Gedeon Richter
      • 12.8.1 Gedeon Richter Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Antidepressants Drugs Introduction
      • 12.8.4 Gedeon Richter Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.8.5 Gedeon Richter Recent Development
    • 12.9 Janssen Pharmaceuticals
      • 12.9.1 Janssen Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Antidepressants Drugs Introduction
      • 12.9.4 Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.9.5 Janssen Pharmaceuticals Recent Development
    • 12.10 Lupin Pharmaceuticals
      • 12.10.1 Lupin Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Antidepressants Drugs Introduction
      • 12.10.4 Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2014-2019)
      • 12.10.5 Lupin Pharmaceuticals Recent Development
    • 12.11 Luye Pharma
    • 12.12 MSI Methylation Sciences
    • 12.13 Naurex
    • 12.14 SK Biopharmaceuticals

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions.
      In 2018, the global Antidepressants Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Antidepressants Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antidepressants Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Pfizer
      AstraZeneca
      Eli Lilly and Company
      Novartis
      GlaxoSmithKline
      Otsuka Pharmaceutical
      Abbott Laboratories
      Gedeon Richter
      Janssen Pharmaceuticals
      Lupin Pharmaceuticals
      Luye Pharma
      MSI Methylation Sciences
      Naurex
      SK Biopharmaceuticals

      Market segment by Type, the product can be split into
      Tricyclic Antidepressants
      Serotonin-norepinephrine Inhibitors
      Atypical Antipsychotics
      Selective Serotonin Reuptake Inhibitors
      Benzodiazepines
      Tetracyclic Antidepressants
      Monoamine Oxidase Inhibitors
      Others

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Antidepressants Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Antidepressants Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Antidepressants Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now